News
Robin Collins is a self-described “little old lady.” She’s 4 feet tall in her wheelchair and unexpectedly hurtling toward age ...
Guest writer Robin Collins, who's approaching 70, has adjusted to losses and survivor's guilt while finding solace in ...
A new ASAH1 mutation linked to SMA with progressive myoclonic epilepsy was found in a young boy, offering insights for ...
Columnist Helen Baldwin says she's come to appreciate the people she's met in the community years after her son's SMA ...
For columnist Connie Chandler, finding a community filled with love, admiration, and support has made all the difference in ...
Upgrades to the home of a person with spinal muscular atrophy can ease daily SMA accessibility challenges and support greater ...
Molecular markers in cerebrospinal fluid may help predict if people with SMA type 2 or type 3 will respond to treatment with Spinraza.
After a weekend with her SMA community, columnist Brianna Albers faces a difficult truth: Some things are hers to achieve, and some are not.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results